• 1053 Citations
  • 18 h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Bradley A. Schiff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma

Ow, T. J., Thomas, C., Fulcher, C. D., Chen, J., López, A., Reyna, D. E., Prystowsky, M. B., Smith, R. V., Schiff, B. A., Rosenblatt, G., Belbin, T. J., Harris, T. M., Childs, G. C., Kawachi, N., Schlecht, N. F. & Gavathiotis, E., Jan 1 2020, (Accepted/In press) In : Laryngoscope.

Research output: Contribution to journalArticle

  • 2 Scopus citations

    The safety and efficacy of open bedside tracheotomy: A retrospective analysis of 1000 patients

    Liao, D. Z., Mehta, V., Kinkhabwala, C. M., Li, D., Palsen, S. & Schiff, B. A., May 1 2020, In : Laryngoscope. 130, 5, p. 1263-1269 7 p.

    Research output: Contribution to journalArticle

  • Association of Delayed Time to Treatment Initiation with Overall Survival and Recurrence among Patients with Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population

    Liao, D. Z., Schlecht, N. F., Rosenblatt, G., Kinkhabwala, C. M., Leonard, J. A., Ference, R. S., Prystowsky, M. B., Ow, T. J., Schiff, B. A., Smith, R. V. & Mehta, V., Nov 2019, In : JAMA Otolaryngology - Head and Neck Surgery. 145, 11, p. 1001-1009 9 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Comparison of Bethesda cytopathology classification to surgical pathology across racial-ethnic groups

    Bresler, A., Mehta, V., Schiff, B. A., Smith, R. V., Khader, S. N., Ramos-Rivera, G., Lin, J., Libutti, S. K., Laird, A. M. & Ow, T. J., Jul 1 2019, In : Head and Neck. 41, 7, p. 2340-2345 6 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Erratum: Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690)

    Schiff, B. A., McMurphy, A. B., Jasser, S. A., Youne, M. N., Doan, D., Yigitbasi, O. G., Kim, S., Zhou, G., Mandal, M., Bekele, B. N., Holsinger, FC. C., Sherman, S. I., Yeung, S. C., El-Naggar, A. K. & Myers, J. N., Aug 1 2019, In : Clinical Cancer Research. 25, 15, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access